Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 51 minutes ago
Back to Filings
FORM 144
AI

144 - December 15, 2025

Filed December 15, 2025
·
0001958244-25-004549

CEO Peter Beck to sell 2.5M RKLB shares worth $138.5M under 10b5-1 plan.

Brief

Form 144 discloses Rocket Lab CEO Peter Beck's proposed sale of 2,500,000 Class A shares valued at $138.5 million on December 15, 2025. Shares, acquired via 2021 business combination conversion, will be sold by Equatorial Trust under a Rule 10b5-1 plan adopted June 13, 2025. Recent September 2025 sales by the Trust totaled ~2.5M shares for $127.5M; relevant for tracking insider liquidity amid RKLB's growth.

Detailed Brief

This Form 144 filing notifies the SEC of an affiliate's (CEO Peter Beck) proposed sale of restricted securities under Rule 144, allowing non-registered resale after holding periods. Beck, Rocket Lab's founder and CEO, plans to sell 2.5 million Class A common shares (0.47% of 534M outstanding) through Goldman Sachs, with market value $138.5M based on ~$55.41/share. Shares originated from preferred stock conversion in the August 2021 SPAC merger with Vector Acquisition Corp. Sales are pursuant to a pre-arranged June 13, 2025, Rule 10b5-1(c) plan by Equatorial Trust (Beck-related entity), which sold 1.06M shares on 9/15/2025 ($57.4M) and 1.44M on 9/16/2025 ($70M). Beck certifies no undisclosed material adverse info as of plan adoption. For Rocket Lab, a space launch/ satellite firm, this reflects executive diversification post-public, common in high-growth tech without signaling distress due to 10b5-1 safeguards.

Key Telemetry

  • Peter Beck proposes sale of 2,500,000 Class A shares ($138.5M aggregate value) on 12/15/2025.
  • Sales by Equatorial Trust under Rule 10b5-1 plan adopted 6/13/2025.
  • Prior 3-month sales: 2.5M shares in Sep 2025 for $127.5M total.
  • Shares from 8/25/2021 preferred conversion in SPAC merger.
  • ~0.47% of 534M outstanding shares.

Impact Vector

For RKLB investors, this is routine CEO liquidity via pre-planned 10b5-1 sales (~5M shares in 3 months), unlikely signaling concerns given certification of no adverse info. Near-term, minimal dilution/price pressure (0.47% float); strategically, supports executive retention in capital-intensive space sector. Monitor future 144s, Form 4s, or Q4 earnings for sales pace, stock performance, and launch cadence.

Search
Search across missions, customers, news, and SEC filings